NASDAQ
No price data available for this timeframe.
Beam Therapeutics Inc. (BEAM) has a current ratio of 13.09x as of Monday, May 25, 2026. This represents a 142.74% increase compared to its 12-month average of 5.39x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.